Arbutus Biopharma Corp Income (Loss) from Continuing Operations before Income Taxes, Domestic
Arbutus Biopharma Corp (ABUS) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $11.95 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-23
- Arbutus Biopharma Corp income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $11.95M.
- Arbutus Biopharma Corp income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$1.67M.
- Arbutus Biopharma Corp income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$14.80M.
- Arbutus Biopharma Corp income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$28.70M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | $11.95M 10-K · filed 2026-03-23 | |
| 2024-12-31 | -$1.67M 10-K · filed 2026-03-23 | -$1.60M 10-K · filed 2025-03-27 |
| 2023-12-31 | -$14.80M 10-K · filed 2025-03-27 | |
| 2022-12-31 | -$28.70M 10-K · filed 2024-03-05 | |
| 2021-12-31 | -$7.70M 10-K · filed 2023-03-02 | |
| 2020-12-31 | -$1.80M 10-K · filed 2022-03-03 | |
| 2019-12-31 | -$27.10M 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |